Kolexia
Schurhoff Franck Psychiatrie
Schurhoff Franck
Psychiatrie
Hôpital Albert Chenevier
Créteil, France
184 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Inflammation Syndrome métabolique X Prédisposition génétique à une maladie Trouble lié au tabagisme Agitation psychomotrice Hallucinations Obésité Obésité abdominale Abus de marijuana

Collaborateurs

Voir plus
Leboyer Marion
Leboyer Marion
Hôpital Albert Chenevier, Créteil, France
Llorca Pierre-Michel
Llorca Pierre-Michel
Chu Psychiatrie, Clermont-Ferrand, France
Fond Guillaume
Fond Guillaume
Hôpital La Conception, Marseille, France
Misdrahi David
Misdrahi David
Hôpital Charles Perrens, Bordeaux, France

Industries

Voir plus
Inter-View Partners France
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study.
Psychological medicine   30 janvier 2024
Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset.
Schizophrenia research   19 décembre 2023
Urbanicity and psychotic disorders: Facts and hypotheses.
Dialogues in clinical neuroscience   23 novembre 2023
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
Translational psychiatry   07 novembre 2023
Poverty and inequality in real-world schizophrenia: a national study.
Frontiers in public health   31 octobre 2023
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
BMJ mental health   23 octobre 2023
The risk of hospitalization for psychotic disorders following hospitalization for COVID-19: a French nationwide longitudinal study.
Molecular psychiatry   03 août 2023
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
Psychological medicine   04 mai 2023
VALITEM: Validation of an Ecological Assessment of Executive Function (Multiple Errands Test) in Patients With Schizophrenia : Study of Discriminant Validity
Essai Clinique (Assistance publique – Hôpitaux de Paris)   29 mars 2023
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Journal of psychiatric research   13 mars 2023